|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.49 USD | -4.00% |
|
-6.66% | -17.01% |
| 02-17 | Citigroup Adjusts Price Target on HP to $20 From $22, Maintains Neutral Rating | MT |
| 02-12 | S&P 500, Dow gain as markets cheer resilient economy, focus shifts to earnings | RE |
| Fiscal Period: October | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 9.91 | 8.5 | 6.99 | 6.85 | 5.59 | |||||
Return on Total Capital | 58.94 | 39.52 | 27.68 | 27.26 | 22.69 | |||||
Return On Equity % | -335.38 | -140.24 | -159.4 | -232.02 | -303.06 | |||||
Return on Common Equity | -335.38 | -140.24 | -159.4 | -232.02 | -303.06 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 21.13 | 19.58 | 21.42 | 22.07 | 20.6 | |||||
SG&A Margin | 8.73 | 8.36 | 9.97 | 10.54 | 10.48 | |||||
EBITDA Margin % | 10.39 | 9.57 | 9.45 | 9.42 | 8.09 | |||||
EBITA Margin % | 9.4 | 8.7 | 8.51 | 8.46 | 7.06 | |||||
EBIT Margin % | 9.15 | 8.34 | 7.86 | 7.87 | 6.6 | |||||
Income From Continuing Operations Margin % | 10.24 | 5.09 | 6.07 | 5.18 | 4.57 | |||||
Net Income Margin % | 10.24 | 5.09 | 6.07 | 5.18 | 4.57 | |||||
Net Avail. For Common Margin % | 10.24 | 5.09 | 6.07 | 5.18 | 4.57 | |||||
Normalized Net Income Margin | 5.45 | 4.98 | 4.35 | 4.28 | 3.47 | |||||
Levered Free Cash Flow Margin | 6.32 | 3.96 | 5.51 | 6.12 | 4.33 | |||||
Unlevered Free Cash Flow Margin | 6.57 | 4.32 | 6.15 | 6.65 | 4.82 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.73 | 1.63 | 1.42 | 1.39 | 1.35 | |||||
Fixed Assets Turnover | 16.99 | 16.26 | 13.39 | 13.23 | 13.39 | |||||
Receivables Turnover (Average Receivables) | 11.66 | 12.53 | 12.23 | 11.45 | 10.23 | |||||
Inventory Turnover (Average Inventory) | 7.21 | 6.52 | 5.83 | 5.73 | 5.41 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.76 | 0.76 | 0.73 | 0.72 | 0.77 | |||||
Quick Ratio | 0.45 | 0.38 | 0.39 | 0.44 | 0.42 | |||||
Operating Cash Flow to Current Liabilities | 0.22 | 0.17 | 0.15 | 0.13 | 0.13 | |||||
Days Sales Outstanding (Average Receivables) | 31.31 | 29.14 | 29.84 | 31.96 | 35.67 | |||||
Days Outstanding Inventory (Average Inventory) | 50.64 | 55.94 | 62.59 | 63.93 | 67.47 | |||||
Average Days Payable Outstanding | 107.95 | 113.75 | 129.2 | 132.95 | 142.73 | |||||
Cash Conversion Cycle (Average Days) | -26 | -28.67 | -36.77 | -37.06 | -39.58 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | -533.45 | -423.99 | -1.01K | -825.47 | -3.15K | |||||
Total Debt / Total Capital | 123.07 | 130.87 | 110.99 | 113.78 | 103.28 | |||||
LT Debt/Equity | -445.21 | -402.64 | -948.27 | -684.88 | -2.78K | |||||
Long-Term Debt / Total Capital | 102.71 | 124.28 | 104.2 | 94.4 | 91.46 | |||||
Total Liabilities / Total Assets | 104.27 | 107.56 | 102.89 | 103.32 | 100.83 | |||||
EBIT / Interest Expense | 22.88 | 14.62 | 7.71 | 9.32 | 8.49 | |||||
EBITDA / Interest Expense | 27.29 | 17.72 | 9.87 | 11.9 | 11.22 | |||||
(EBITDA - Capex) / Interest Expense | 25 | 15.52 | 8.76 | 10.59 | 9.13 | |||||
Total Debt / EBITDA | 1.27 | 1.94 | 2 | 2.03 | 2.26 | |||||
Net Debt / EBITDA | 0.65 | 1.45 | 1.42 | 1.43 | 1.49 | |||||
Total Debt / (EBITDA - Capex) | 1.39 | 2.22 | 2.25 | 2.28 | 2.77 | |||||
Net Debt / (EBITDA - Capex) | 0.71 | 1.66 | 1.6 | 1.6 | 1.83 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 12.09 | -0.79 | -14.61 | -0.3 | 3.24 | |||||
Gross Profit, 1 Yr. Growth % | 28.55 | -8.06 | -6.16 | 2.69 | -3.6 | |||||
EBITDA, 1 Yr. Growth % | 38.75 | -5.23 | -13.97 | -2.78 | -11.3 | |||||
EBITA, 1 Yr. Growth % | 46.27 | -4.43 | -14.44 | -3.33 | -13.88 | |||||
EBIT, 1 Yr. Growth % | 46.56 | -5.88 | -17.47 | -2.86 | -13.38 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 128.66 | -50.75 | 4.18 | -14.96 | -8.86 | |||||
Net Income, 1 Yr. Growth % | 128.66 | -50.75 | 4.18 | -14.96 | -8.86 | |||||
Normalized Net Income, 1 Yr. Growth % | 45.95 | -9.41 | -23.49 | -1.87 | -16.37 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 166.5 | -42.78 | 9.4 | -13.8 | -5.69 | |||||
Accounts Receivable, 1 Yr. Growth % | 2.42 | -17.51 | -6.8 | 20.77 | 11.24 | |||||
Inventory, 1 Yr. Growth % | 32.99 | -4.22 | -9.88 | 12.5 | 10.26 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 0.11 | 7.28 | 0.12 | 1.59 | 2.43 | |||||
Total Assets, 1 Yr. Growth % | 11.33 | -0.06 | -3.87 | 7.85 | 4.66 | |||||
Tangible Book Value, 1 Yr. Growth % | 0.97 | 44.98 | -16.64 | 0.14 | -10.69 | |||||
Common Equity, 1 Yr. Growth % | -25.94 | 76.85 | -64.66 | 23.76 | -73.85 | |||||
Cash From Operations, 1 Yr. Growth % | 48.49 | -30.36 | -19.99 | 4.98 | -1.39 | |||||
Capital Expenditures, 1 Yr. Growth % | 0.34 | 35.91 | -23.01 | -0.17 | 51.52 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 22.24 | -35.47 | 17.8 | 3.36 | -26.87 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 21.54 | -32.44 | 20.65 | 1.32 | -25.12 | |||||
Dividend Per Share, 1 Yr. Growth % | 10.74 | 28.21 | 5 | 4.99 | 5.24 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 3.95 | 5.45 | -8 | -7.73 | 1.46 | |||||
Gross Profit, 2 Yr. CAGR % | 9.6 | 8.71 | -7.35 | -1.83 | -0.51 | |||||
EBITDA, 2 Yr. CAGR % | 14.68 | 10.42 | -11.39 | -10.47 | -7.14 | |||||
EBITA, 2 Yr. CAGR % | 16.61 | 13.27 | -11.43 | -11.15 | -8.76 | |||||
EBIT, 2 Yr. CAGR % | 16.64 | 12.38 | -13.74 | -12.57 | -8.27 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 43.64 | 6.12 | -29.37 | -5.87 | -11.96 | |||||
Net Income, 2 Yr. CAGR % | 43.64 | 6.12 | -29.37 | -5.87 | -11.96 | |||||
Normalized Net Income, 2 Yr. CAGR % | 39.64 | 14.99 | -18.31 | -13.35 | -9.41 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 60.46 | 23.49 | -22.01 | -2.89 | -9.84 | |||||
Accounts Receivable, 2 Yr. CAGR % | -4.41 | -8.09 | -12.32 | 6.09 | 15.91 | |||||
Inventory, 2 Yr. CAGR % | 17.6 | 12.86 | -6.98 | 0.69 | 11.38 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 15.67 | 3.63 | 3.64 | 0.86 | 2.01 | |||||
Total Assets, 2 Yr. CAGR % | 7.41 | 5.48 | -2.1 | 1.82 | 6.24 | |||||
Tangible Book Value, 2 Yr. CAGR % | 5.97 | 20.99 | 10.37 | -8.63 | -5.43 | |||||
Common Equity, 2 Yr. CAGR % | 17.6 | 14.44 | -19.51 | -33.87 | -43.11 | |||||
Cash From Operations, 2 Yr. CAGR % | 17.35 | 1.69 | -25.36 | -8.35 | 1.75 | |||||
Capital Expenditures, 2 Yr. CAGR % | -6.87 | 16.78 | 2.29 | -12.03 | 22.99 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -0.14 | -14.42 | -13.18 | 8.49 | -13.11 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -0.04 | -12.55 | -10.09 | 8.77 | -12.95 | |||||
Dividend Per Share, 2 Yr. CAGR % | 10.06 | 19.52 | 16.02 | 5 | 5 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 2.78 | 2.34 | -1.75 | -5.5 | -4.21 | |||||
Gross Profit, 3 Yr. CAGR % | 7.94 | 3.36 | 3.31 | -4.12 | -2.43 | |||||
EBITDA, 3 Yr. CAGR % | 10.82 | 6.34 | 0.86 | -7.93 | -10.75 | |||||
EBITA, 3 Yr. CAGR % | 10.68 | 7.68 | 2.32 | -8.06 | -12.07 | |||||
EBIT, 3 Yr. CAGR % | 10.4 | 7.12 | 0.53 | -9.46 | -12.84 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 6.88 | 0.54 | 4.69 | -24.86 | -6.88 | |||||
Net Income, 3 Yr. CAGR % | 6.88 | 0.54 | 4.69 | -24.86 | -6.88 | |||||
Normalized Net Income, 3 Yr. CAGR % | 17.71 | 20.88 | -0.5 | -13.17 | -14.37 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 17.81 | 13.79 | 17.69 | -19.37 | -3.84 | |||||
Accounts Receivable, 3 Yr. CAGR % | 2.53 | -8.99 | -7.66 | -2.44 | 7.78 | |||||
Inventory, 3 Yr. CAGR % | 9.37 | 9.82 | 4.79 | -0.89 | 3.79 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 19.36 | 12.8 | 2.45 | 2.95 | 1.38 | |||||
Total Assets, 3 Yr. CAGR % | 3.7 | 4.86 | 2.18 | 1.11 | 2.76 | |||||
Tangible Book Value, 3 Yr. CAGR % | 9.37 | 17.64 | 7.15 | 6.85 | -9.32 | |||||
Common Equity, 3 Yr. CAGR % | 37.19 | 34.74 | -21.71 | -7.1 | -51.46 | |||||
Cash From Operations, 3 Yr. CAGR % | 12.28 | -1.39 | -6.12 | -16.37 | -6.08 | |||||
Capital Expenditures, 3 Yr. CAGR % | 2.15 | 5.64 | 1.64 | 0.57 | 5.45 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 2.35 | -14.76 | -4.56 | -5.84 | -4.91 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 1.95 | -13.34 | -2.42 | -4.48 | -3.99 | |||||
Dividend Per Share, 3 Yr. CAGR % | 11.45 | 16.04 | 14.47 | 12.22 | 5 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 5.65 | 3.88 | -1.68 | -1.84 | -0.48 | |||||
Gross Profit, 5 Yr. CAGR % | 8.32 | 5.19 | 1.53 | 1.13 | 1.77 | |||||
EBITDA, 5 Yr. CAGR % | 9.08 | 6.71 | 0.92 | 0.12 | -1.99 | |||||
EBITA, 5 Yr. CAGR % | 8.56 | 6.46 | 0.78 | 0.65 | -1.78 | |||||
EBIT, 5 Yr. CAGR % | 8.08 | 5.56 | -0.44 | -0.27 | -2.57 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 19.52 | 4.86 | -9.34 | -2.52 | -2.32 | |||||
Net Income, 5 Yr. CAGR % | 21.11 | 4.86 | -9.34 | -2.52 | -2.32 | |||||
Normalized Net Income, 5 Yr. CAGR % | 5.92 | 5.91 | 1.94 | 5.25 | -4.17 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 28.35 | 15.56 | 0 | 6.3 | 5.79 | |||||
Accounts Receivable, 5 Yr. CAGR % | 6.02 | 0.59 | -3.69 | -3.23 | 1.13 | |||||
Inventory, 5 Yr. CAGR % | 12.08 | 5.59 | 2.51 | 6.13 | 7.38 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 16.58 | 16.38 | 12.81 | 7.86 | 2.27 | |||||
Total Assets, 5 Yr. CAGR % | 5.9 | 3.23 | 1.34 | 3.58 | 3.79 | |||||
Tangible Book Value, 5 Yr. CAGR % | -0.58 | 8.19 | 9.77 | 6.5 | 1.93 | |||||
Common Equity, 5 Yr. CAGR % | -15.76 | -3.06 | 10.84 | 2.09 | -31.1 | |||||
Cash From Operations, 5 Yr. CAGR % | 14.53 | 3.95 | -4.64 | -4.23 | -3.05 | |||||
Capital Expenditures, 5 Yr. CAGR % | 6.09 | 14.5 | 2.21 | -2.47 | 9.11 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -21.1 | -4.28 | -4.6 | -4.03 | -6.8 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -20.69 | -3.79 | -3.47 | -3.14 | -5.61 | |||||
Dividend Per Share, 5 Yr. CAGR % | 9.17 | 13.54 | 13.4 | 11.49 | 10.58 |
- Stock Market
- Equities
- HPQ Stock
- Financials HP Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















